High-Dose Inactivated Influenza Vaccine Linked to Lower Rates of Hospitalization in HF
Patients with heart failure who receive a high-dose inactivated influenza vaccine have a decreased risk for hospitalization.
A study in Circulation: Heart Failure found that high-dose inactivated influenza vaccine (HD-IIV) is associated with reduced rates of hospitalizations related to laboratory-confirmed influenza, cardiorespiratory disease, cardiovascular disease, and heart failure in patients with HF.
- The study analyzed data from the DANFLU-2 trial, conducted in Denmark over three consecutive influenza seasons (2022-2025).
- The trial included individuals aged 65 and older, randomly assigned to receive either HD-IIV or standard-dose inactivated influenza vaccine (SD-IIV).
No direct quote available in the text.
Author's summary: High-dose flu vaccine reduces hospitalization risk in heart failure patients.
More News
- Two Man City stars shine vs Swansea as Pep Guardiola given £70m January transfer conundrum
- Bennie Thompson: Mississippi’s families deserve affordable health care, not political roulette
- Rethinking human roles in AI warfare – Peace Research Institute Oslo (PRIO)
- Xinhua Silk Road: Industrial and financial synergetic development to be engine for Northeast Asia's economy
- Wizz Air reintroduces its “All You Can Fly” pass for unlimited travel!
- Misrata Youth and Revolutionaries Movement: Misratans who met Khaled Haftar represent only themselves
- Danielle Smith: Balancing the budget gets a lot easier if you build a pipeline
- Hong Kong LinkedIn users urged to check privacy settings as AI training to resume
- Fukuoka to Upgrade School Kitchens | Fukuoka Now
- Acer Unveils Aspire 14 AI Laptops with Ryzen AI 7 350 Processor